- HER2 negative
- ER positive
- HER2 positive
- PD-L1 positive
- EGFR positive
- PR positive
- KRAS positive
- PR negative
- ER negative
- BRAF positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1 or more Prior Treatment Regimens
- >= 2 Bone Metastases (Untreated Lesion)
- ALK-targeted therapy
- ANC >= 1,500/mcL
- AST/ALT =< 3 x ULN
- Chemotherapy
- Endocrine Therapy
- Radiation Therapy
- Trastuzumab
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
6583 trials
Trials Without a Placebo
1
2
3
…50